CLINICAL RESEARCH: CLINICAL TRIALS
Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation
Outcomes from a controlled nonrandomized long-term study
Carlo Pappone, MD, PhD*,*,
Salvatore Rosanio, MD, PhD*,
Giuseppe Augello, MD*,
Giuseppe Gallus, PhD ,
Gabriele Vicedomini, MD*,
Patrizio Mazzone, MD*,
Simone Gulletta, MD*,
Filippo Gugliotta, RT*,
Alessia Pappone, MD*,
Vincenzo Santinelli, MD*,
Valter Tortoriello, MD*,
Simone Sala, MD*,
Alberto Zangrillo, MD ,
Giuseppe Crescenzi, MD ,
Stefano Benussi, MD and
Ottavio Alfieri, MD
* Clinical Cardiac Electrophysiology and Pacing Unit, Department of Cardiology, San Raffaele University Hospital, Milan, Italy
Institute of Medical Statistics, University of Milan, Milan, Italy
Division of Anesthesiology and Intensive Care, San Raffaele University Hospital, Milan, Italy
Cardiothoracic Surgery Unit, Department of Cardiology, San Raffaele University Hospital, Milan, Italy
Manuscript received October 25, 2002;
revised manuscript received January 23, 2003,
accepted January 30, 2003.
* Reprint requests and correspondence: Dr. Carlo Pappone, Department of Cardiology, San Raffaele University Hospital, Via Olgettina 60, 20132 Milan, Italy. salvatore.rosanio{at}hsr.it
Presented in part at the 75th Annual Scientific Sessions of the American Heart Association, November 2002, and 52nd Annual Scientific Sessions of the American College of Cardiology, March 2003.
OBJECTIVES: This study was designed to investigate the potential of circumferential pulmonary vein (PV) ablation for atrial fibrillation (AF) to maintain sinus rhythm (SR) over time, thus reducing mortality and morbidity while enhancing quality of life (QoL).
BACKGROUND: Circumferential PV ablation is safe and effective, but the long-term outcomes and its impact on QoL have not been assessed or compared with those for medical therapy.
METHODS: We examined the clinical course of 1,171 consecutive patients with symptomatic AF who were referred to us between January 1998 and March 2001. The 589 ablated patients were compared with the 582 who received antiarrhythmic medications for SR control. The QoL of 109 ablated and 102 medically treated patients was measured with the SF-36 survey.
RESULTS: Median follow-up was 900 days (range 161 to 1,508 days). Kaplan-Meier analysis showed observed survival for ablated patients was longer than among patients treated medically (p < 0.001), and not different from that expected for healthy persons of the same gender and calendar year of birth (p = 0.55). Cox proportional-hazards model revealed in the ablation group hazard ratios of 0.46 (95% confidence interval [CI], 0.31 to 0.68; p < 0.001) for all-cause mortality, of 0.45 (95% CI, 0.31 to 0.64; p < 0.001) for morbidities mainly due to heart failure and ischemic cerebrovascular events, and of 0.30 (95% CI, 0.24 to 0.37; p < 0.001) for AF recurrence. Ablated patients QoL, different from patients treated medically, reached normative levels at six months and remained unchanged at one year.
CONCLUSIONS: Pulmonary vein ablation improves mortality, morbidity, and QoL as compared with medical therapy. Our findings pave the way for randomized trials to prospect a wider application of ablation therapy for AF.
|
Abbreviations and Acronyms
| | AF | = atrial fibrillation | | CAD | = coronary artery disease | | CI | = confidence interval | | ECG | = electrocardiogram | | HR | = hazard ratio | | LA | = left atrial/atrium | | MI | = myocardial infarction | | PV | = pulmonary vein | | QoL | = quality of life | | RF | = radiofrequency | | SR | = sinus rhythm |
|
This article has been cited by other articles:

|
 |

|
 |
 
C McKenna, S Palmer, M Rodgers, D Chambers, N Hawkins, S Golder, S Van Hout, C Pepper, D Todd, and N Woolacott
Cost-effectiveness of radiofrequency catheter ablation for the treatment of atrial fibrillation in the United Kingdom
Heart,
April 1, 2009;
95(7):
542 - 549.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Masroor
Invited Commentary
Ann. Thorac. Surg.,
December 1, 2008;
86(6):
1882 - 1882.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. H. Hauser, D. C. Peters, J. V. Wylie, and W. J. Manning
Evaluating the left atrium by magnetic resonance imaging
Europace,
November 1, 2008;
10(suppl_3):
iii22 - iii27.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. N. Khan, P. Jais, J. Cummings, L. Di Biase, P. Sanders, D. O. Martin, J. Kautzner, S. Hao, S. Themistoclakis, R. Fanelli, et al.
Pulmonary-Vein Isolation for Atrial Fibrillation in Patients with Heart Failure
N. Engl. J. Med.,
October 23, 2008;
359(17):
1778 - 1785.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. L Bayard, S. H Ostermayer, and H. Sievert
Alternatives to warfarin in atrial fibrillation: drugs and devices
Heart,
September 1, 2008;
94(9):
1113 - 1116.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. De Piccoli, A. Rossillo, C. Zanella, A. Bonso, S. Themistoclakis, A. Corrado, and A. Raviele
Role of transoesophageal echocardiography in evaluating the effect of catheter ablation of atrial fibrillation on anatomy and function of the pulmonary veins
Europace,
September 1, 2008;
10(9):
1079 - 1084.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Aliot and J. N. Ruskin
Controversies in ablation of atrial fibrillation
Eur. Heart J. Suppl.,
September 1, 2008;
10(suppl_H):
H32 - H54.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Neumann, J. Vogt, B. Schumacher, A. Dorszewski, M. Kuniss, H. Neuser, K. Kurzidim, A. Berkowitsch, M. Koller, J. Heintze, et al.
Circumferential Pulmonary Vein Isolation With the Cryoballoon Technique: Results From a Prospective 3-Center Study
J. Am. Coll. Cardiol.,
July 22, 2008;
52(4):
273 - 278.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. C. Babaliaros, J. T. Green, S. Lerakis, M. Lloyd, and P. C. Block
Emerging applications for transseptal left heart catheterization old techniques for new procedures.
J. Am. Coll. Cardiol.,
June 3, 2008;
51(22):
2116 - 2122.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Lencioni, S. Muhyaldeen, H. Marshall, and M. Griffith
Verification of electrical isolation of pulmonary veins following left atrial circumferential ablation may require sinus rhythm
Europace,
May 1, 2008;
10(5):
606 - 608.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Blanc, J. Almendral, M. Brignole, M. Fatemi, K. Gjesdal, E. Gonzalez-Torrecilla, P. Kulakowski, G. Y.H. Lip, D. Shah, C. Wolpert, et al.
Consensus document on antithrombotic therapy in the setting of electrophysiological procedures
Europace,
May 1, 2008;
10(5):
513 - 527.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A Lubitz, A. Fischer, and V. Fuster
Catheter ablation for atrial fibrillation
BMJ,
April 12, 2008;
336(7648):
819 - 826.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Katritsis, M. A. Wood, E. Giazitzoglou, R. K. Shepard, G. Kourlaba, and K. A. Ellenbogen
Long-term follow-up after radiofrequency catheter ablation for atrial fibrillation
Europace,
April 1, 2008;
10(4):
419 - 424.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Noheria, A. Kumar, J. V. Wylie Jr, and M. E. Josephson
Catheter Ablation vs Antiarrhythmic Drug Therapy for Atrial Fibrillation: A Systematic Review
Arch Intern Med,
March 24, 2008;
168(6):
581 - 586.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Lonnerholm, P. Blomstrom, L. Nilsson, and C. Blomstrom-Lundqvist
Long-Term Effects of the Maze Procedure on Atrial Size and Mechanical Function
Ann. Thorac. Surg.,
March 1, 2008;
85(3):
916 - 920.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E.W. Hemels, J. H. Ruiter, G. P. Molhoek, N. J.G.M. Veeger, A. C.P. Wiesfeld, A. V. Ranchor, M. van Trigt, A. Pilmeyer, I. C. Van Gelder, and for The Features in AT500TM study; Chances for pat
Right atrial preventive and antitachycardia pacing for prevention of paroxysmal atrial fibrillation in patients without bradycardia: a randomized study
Europace,
March 1, 2008;
10(3):
306 - 313.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Nademanee, M. C. Schwab, E. M. Kosar, M. Karwecki, M. D. Moran, N. Visessook, A. D. Michael, and T. Ngarmukos
Clinical Outcomes of Catheter Substrate Ablation for High-Risk Patients With Atrial Fibrillation
J. Am. Coll. Cardiol.,
February 26, 2008;
51(8):
843 - 849.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Deneke, K. Khargi, B. Lemke, T. Lawo, M. Lindstaedt, A. Germing, T. Brodherr, L. Bosche, A. Mugge, A. Laczkovics, et al.
Intra-operative cooled-tip radiofrequency linear atrial ablation to treat permanent atrial fibrillation
Eur. Heart J.,
December 1, 2007;
28(23):
2909 - 2914.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Pappone and V. Santinelli
Non-fluoroscopic mapping as a guide for atrial ablation: current status and expectations for the future
Eur. Heart J. Suppl.,
December 1, 2007;
9(suppl_I):
I36 - I47.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Lamotte, L. Annemans, B. Bridgewater, S. Kendall, and M. Siebert
A health economic evaluation of concomitant surgical ablation for atrial fibrillation
Eur. J. Cardiothorac. Surg.,
November 1, 2007;
32(5):
702 - 710.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Gillinov
Choice of Surgical Lesion Set: Answers From the Data
Ann. Thorac. Surg.,
November 1, 2007;
84(5):
1786 - 1792.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Friberg, N. Hammar, H. Pettersson, and M. Rosenqvist
Increased mortality in paroxysmal atrial fibrillation: report from the Stockholm Cohort-Study of Atrial Fibrillation (SCAF)
Eur. Heart J.,
October 1, 2007;
28(19):
2346 - 2353.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D. O'Neill, P. Jais, M. Hocini, F. Sacher, G. J. Klein, J. Clementy, and M. Haissaguerre
Catheter Ablation for Atrial Fibrillation
Circulation,
September 25, 2007;
116(13):
1515 - 1523.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Calkins, J. Brugada, D. L. Packer, R. Cappato, S.-A. Chen, H. J.G. Crijns, R. J. Damiano Jr, D. W. Davies, D. E. Haines, M. Haissaguerre, et al.
HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Personnel, Policy, Procedures and Follow-Up: A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation Developed in partnership with the European Heart Rhythm Association (EHRA) and the European Cardiac Arrhythmia Society (ECAS); in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Endorsed and Approved by the governing bodies of the American College of Cardiology, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, and the Heart Rhythm Society.
Europace,
June 1, 2007;
9(6):
335 - 379.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. N. Graham, I. C. Melton, S. MacDonald, and I. G. Crozier
Value of CT localization of the fossa ovalis prior to transseptal left heart catheterization for left atrial ablation
Europace,
June 1, 2007;
9(6):
417 - 423.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E.W. Hemels, A. C.P. Wiesfeld, D. J. Van Veldhuisen, M. P. Van den Berg, and I. C. Van Gelder
Outcome of pharmacological rhythm control for new-onset persistent atrial fibrillation in patients with systolic heart failure: a comparison with patients with normal left ventricular function
Europace,
April 1, 2007;
9(4):
239 - 245.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Bertaglia, G. Stabile, G. Senatore, A. Colella, M. Del Greco, H. Goessinger, F. Lamberti, M. Lowe, R. Mantovan, N. Peters, et al.
A clinical and health-economic evaluation of pulmonary vein encircling ablation compared with antiarrhythmic drug treatment in patients with persistent atrial fibrillation (Catheter Ablation for the Cure of Atrial Fibrillation-2 study)
Europace,
March 1, 2007;
9(3):
182 - 185.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Olshansky
Placebo and Nocebo in Cardiovascular Health: Implications for Healthcare, Research, and the Doctor-Patient Relationship
J. Am. Coll. Cardiol.,
January 30, 2007;
49(4):
415 - 421.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Pappone, G. Augello, S. Sala, F. Gugliotta, G. Vicedomini, S. Gulletta, G. Paglino, P. Mazzone, N. Sora, I. Greiss, et al.
A Randomized Trial of Circumferential Pulmonary Vein Ablation Versus Antiarrhythmic Drug Therapy in Paroxysmal Atrial Fibrillation: The APAF Study
J. Am. Coll. Cardiol.,
December 5, 2006;
48(11):
2340 - 2347.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. W.W. Wong and K.-H. Mak
Impact of Maze and Concomitant Mitral Valve Surgery on Clinical Outcomes
Ann. Thorac. Surg.,
November 1, 2006;
82(5):
1938 - 1947.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. C. Van Gelder and M. E.W. Hemels
The progressive nature of atrial fibrillation: a rationale for early restoration and maintenance of sinus rhythm
Europace,
November 1, 2006;
8(11):
943 - 949.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E.W. Hemels, T. Van Noord, H. J.G.M. Crijns, D. J. Van Veldhuisen, N. J.G.M. Veeger, H. A. Bosker, A. C.P. Wiesfeld, M. P. Van den Berg, A. V. Ranchor, and I. C. Van Gelder
Verapamil Versus Digoxin and Acute Versus Routine Serial Cardioversion for the Improvement of Rhythm Control for Persistent Atrial Fibrillation
J. Am. Coll. Cardiol.,
September 5, 2006;
48(5):
1001 - 1009.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Writing Committee Members, V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, et al.
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Europace,
September 1, 2006;
8(9):
651 - 745.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Oral, A. Chugh, M. Ozaydin, E. Good, J. Fortino, S. Sankaran, S. Reich, P. Igic, D. Elmouchi, D. Tschopp, et al.
Risk of Thromboembolic Events After Percutaneous Left Atrial Radiofrequency Ablation of Atrial Fibrillation
Circulation,
August 22, 2006;
114(8):
759 - 765.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al.
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
J. Am. Coll. Cardiol.,
August 15, 2006;
48(4):
854 - 906.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al.
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
J. Am. Coll. Cardiol.,
August 15, 2006;
48(4):
e149 - e246.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. N. Singh, X. C. Tang, B. N. Singh, P. Dorian, D. J. Reda, C. L. Harris, R. D. Fletcher, S. C. Sharma, J. E. Atwood, A. K. Jacobson, et al.
Quality of Life and Exercise Performance in Patients in Sinus Rhythm Versus Persistent Atrial Fibrillation: A Veterans Affairs Cooperative Studies Program Substudy
J. Am. Coll. Cardiol.,
August 15, 2006;
48(4):
721 - 730.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Gasparini, A. Auricchio, F. Regoli, C. Fantoni, M. Kawabata, P. Galimberti, D. Pini, C. Ceriotti, E. Gronda, C. Klersy, et al.
Four-Year Efficacy of Cardiac Resynchronization Therapy on Exercise Tolerance and Disease Progression: The Importance of Performing Atrioventricular Junction Ablation in Patients With Atrial Fibrillation
J. Am. Coll. Cardiol.,
August 15, 2006;
48(4):
734 - 743.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al.
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Circulation,
August 15, 2006;
114(7):
e257 - e354.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al.
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Circulation,
August 15, 2006;
114(7):
700 - 752.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Authors/Task Force Members, V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, et al.
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation executive summary: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Eur. Heart J.,
August 2, 2006;
27(16):
1979 - 2030.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Gillinov, S. Bhavani, E. H. Blackstone, J. Rajeswaran, L. G. Svensson, J. L. Navia, B.G. Pettersson, J. F. Sabik III, N. G. Smedira, T. Mihaljevic, et al.
Surgery for Permanent Atrial Fibrillation: Impact of Patient Factors and Lesion Set
Ann. Thorac. Surg.,
August 1, 2006;
82(2):
502 - 514.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Deisenhofer, H. Estner, B. Zrenner, J. Schreieck, S. Weyerbrock, G. Hessling, K. Scharf, M. R. Karch, and C. Schmitt
Left atrial tachycardia after circumferential pulmonary vein ablation for atrial fibrillation: incidence, electrophysiological characteristics, and results of radiofrequency ablation.
Europace,
August 1, 2006;
8(8):
573 - 582.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. S. Chan, S. Vijan, F. Morady, and H. Oral
Cost-Effectiveness of Radiofrequency Catheter Ablation for Atrial Fibrillation
J. Am. Coll. Cardiol.,
June 20, 2006;
47(12):
2513 - 2520.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Takahashi, M. Hocini, M. D. O'Neill, P. Sanders, M. Rotter, T. Rostock, A. Jonsson, F. Sacher, J. Clementy, P. Jais, et al.
Sites of Focal Atrial Activity Characterized by Endocardial Mapping During Atrial Fibrillation
J. Am. Coll. Cardiol.,
May 16, 2006;
47(10):
2005 - 2012.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E.W. Hemels, Y. L. Gu, A. E. Tuinenburg, P. W. Boonstra, A. C.P. Wiesfeld, M. P. van den Berg, D. J. Van Veldhuisen, and I. C. Van Gelder
Favorable long-term outcome of maze surgery in patients with lone atrial fibrillation.
Ann. Thorac. Surg.,
May 1, 2006;
81(5):
1773 - 1779.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. A. Elesber, A. G. Rosales, R. M. Herges, W.-K. Shen, B. S. Moon, J. F. Malouf, N. M. Ammash, V. Somers, D. O. Hodge, B. J. Gersh, et al.
Relapse and mortality following cardioversion of new-onset vs. recurrent atrial fibrillation and atrial flutter in the elderly
Eur. Heart J.,
April 1, 2006;
27(7):
854 - 860.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Oral, C. Pappone, A. Chugh, E. Good, F. Bogun, F. Pelosi Jr., E. R. Bates, M. H. Lehmann, G. Vicedomini, G. Augello, et al.
Circumferential pulmonary-vein ablation for chronic atrial fibrillation.
N. Engl. J. Med.,
March 2, 2006;
354(9):
934 - 941.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Forlani, R. De Paulis, L. G. Wolf, R. Greco, P. Polisca, M. Moscarelli, and L. Chiariello
Conversion to Sinus Rhythm by Ablation Improves Quality of Life in Patients Submitted to Mitral Valve Surgery.
Ann. Thorac. Surg.,
March 1, 2006;
81(3):
863 - 867.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Haissaguerre, M. Hocini, P. Sanders, Y. Takahashi, M. Rotter, F. Sacher, T. Rostock, L.-F. Hsu, A. Jonsson, M. D. O'Neill, et al.
Localized Sources Maintaining Atrial Fibrillation Organized by Prior Ablation
Circulation,
February 7, 2006;
113(5):
616 - 625.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Rienstra, I. C. Van Gelder, V. E. Hagens, N. J.G.M. Veeger, D. J. Van Veldhuisen, H. J.G.M. Crijns, and for the RACE Investigators
Mending the rhythm does not improve prognosis in patients with persistent atrial fibrillation: a subanalysis of the RACE study
Eur. Heart J.,
February 1, 2006;
27(3):
357 - 364.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J Earley and R. J Schilling
Catheter and surgical ablation of atrial fibrillation
Heart,
February 1, 2006;
92(2):
266 - 274.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E.W. Hemels, A. C.P. Wiesfeld, B. Inberg, P. F.H.M. Van Dessel, W. Nieuwland, E. S. Tan, H. Mulder, D. J. Van Veldhuisen, and I. C. Van Gelder
Right atrial overdrive pacing for prevention of symptomatic refractory atrial fibrillation.
Europace,
February 1, 2006;
8(2):
107 - 112.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M C S Hall and D M Todd
Modern management of arrhythmias
Postgrad. Med. J.,
February 1, 2006;
82(964):
117 - 125.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Stabile, E. Bertaglia, G. Senatore, A. De Simone, F. Zoppo, G. Donnici, P. Turco, P. Pascotto, M. Fazzari, and D. F. Vitale
Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation For The Cure Of Atrial Fibrillation Study)
Eur. Heart J.,
January 2, 2006;
27(2):
216 - 221.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Essebag, J. V. Wylie, and M. E. Josephson
Effectiveness of catheter ablation of atrial fibrillation
Eur. Heart J.,
January 2, 2006;
27(2):
130 - 131.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Gillinov, F. Bakaeen, P. M. McCarthy, E. H. Blackstone, J. Rajeswaran, G. Pettersson, J. F. Sabik III, F. Najam, K. M. Hill, L. G. Svensson, et al.
Surgery for Paroxysmal Atrial Fibrillation in the Setting of Mitral Valve Disease: A Role for Pulmonary Vein Isolation?
Ann. Thorac. Surg.,
January 1, 2006;
81(1):
19 - 28.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Hocini, P. Jais, P. Sanders, Y. Takahashi, M. Rotter, T. Rostock, L.-F. Hsu, F. Sacher, S. Reuter, J. Clementy, et al.
Techniques, Evaluation, and Consequences of Linear Block at the Left Atrial Roof in Paroxysmal Atrial Fibrillation: A Prospective Randomized Study
Circulation,
December 13, 2005;
112(24):
3688 - 3696.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. L. Hoppe, A. M. Kahn, G. K. Feld, A. Hassankhani, and S. M. Narayan
Separating Atrial Flutter From Atrial Fibrillation With Apparent Electrocardiographic Organization Using Dominant and Narrow F-Wave Spectra
J. Am. Coll. Cardiol.,
December 6, 2005;
46(11):
2079 - 2087.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Gillinov, J. Sirak, E. H. Blackstone, P. M. McCarthy, J. Rajeswaran, G. Pettersson, F. J. Sabik III, L. G. Svensson, J. L. Navia, D. M. Cosgrove, et al.
The Cox maze procedure in mitral valve disease: Predictors of recurrent atrial fibrillation
J. Thorac. Cardiovasc. Surg.,
December 1, 2005;
130(6):
1653 - 1660.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F R Quinn and A C Rankin
Atrial fibrillation ablation in the real world
Heart,
December 1, 2005;
91(12):
1507 - 1508.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Bisleri and C. Muneretto
Innovative Monolateral Approach for Closed-Chest Atrial Fibrillation Surgery
Ann. Thorac. Surg.,
November 1, 2005;
80(5):
e22 - e25.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. P. Beukema, A. Elvan, H. T. Sie, A. R. Ramdat Misier, and H. J.J. Wellens
Successful Radiofrequency Ablation in Patients With Previous Atrial Fibrillation Results in a Significant Decrease in Left Atrial Size
Circulation,
October 4, 2005;
112(14):
2089 - 2095.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Testa, G. G.L. Biondi-Zoccai, A. D. Russo, F. Bellocci, F. Andreotti, and F. Crea
Rate-control vs. rhythm-control in patients with atrial fibrillation: a meta-analysis
Eur. Heart J.,
October 1, 2005;
26(19):
2000 - 2006.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Verma, A. Natale, B. J. Padanilam, E. N. Prystowsky, A. Verma, A. Natale, B. J. Padanilam, and E. N. Prystowsky
Why Atrial Fibrillation Ablation Should Be Considered First-Line Therapy for Some Patients
Circulation,
August 23, 2005;
112(8):
1214 - 1222.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. J. Padanilam and E. N. Prystowsky
Should Ablation Be First-Line Therapy and for Whom: The Antagonist Position
Circulation,
August 23, 2005;
112(8):
1223 - 1231.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Edelson, R. Shah, and D. Ost
A 45-Year-Old Man With Left Lung Hypoperfusion and Possible Pulmonary Embolism
Chest,
August 1, 2005;
128(2):
1032 - 1036.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Tanner, G. Hindricks, R. Kobza, A. Dorszewski, P. Schirdewahn, C. Piorkowski, J.-H. Gerds-Li, and H. Kottkamp
Trigger Activity More Than Three Years After Left Atrial Linear Ablation Without Pulmonary Vein Isolation in Patients With Atrial Fibrillation
J. Am. Coll. Cardiol.,
July 19, 2005;
46(2):
338 - 343.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Hindricks, C. Piorkowski, H. Tanner, R. Kobza, J.-H. Gerds-Li, C. Carbucicchio, and H. Kottkamp
Perception of Atrial Fibrillation Before and After Radiofrequency Catheter Ablation: Relevance of Asymptomatic Arrhythmia Recurrence
Circulation,
July 19, 2005;
112(3):
307 - 313.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. H. Falk
Rate Control Is Preferable to Rhythm Control in the Majority of Patients With Atrial Fibrillation
Circulation,
June 14, 2005;
111(23):
3141 - 3150.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Zimetbaum
An Argument for Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation
Circulation,
June 14, 2005;
111(23):
3150 - 3156.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. M. Wazni, N. F. Marrouche, D. O. Martin, A. Verma, M. Bhargava, W. Saliba, D. Bash, R. Schweikert, J. Brachmann, J. Gunther, et al.
Radiofrequency Ablation vs Antiarrhythmic Drugs as First-line Treatment of Symptomatic Atrial Fibrillation: A Randomized Trial
JAMA,
June 1, 2005;
293(21):
2634 - 2640.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Hocini, P. Sanders, P. Jais, L.-F. Hsu, R. Weerasoriya, C. Scavee, Y. Takahashi, M. Rotter, F. Raybaud, L. Macle, et al.
Prevalence of pulmonary vein disconnection after anatomical ablation for atrial fibrillation: consequences of wide atrial encircling of the pulmonary veins
Eur. Heart J.,
April 1, 2005;
26(7):
696 - 704.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. D. Bahnson
Clinician's Commentary
Radiology,
April 1, 2005;
235(1):
49 - 50.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. C. Lang, V. Santinelli, G. Augello, A. Ferro, F. Gugliotta, S. Gulletta, G. Vicedomini, C. Mesas, G. Paglino, S. Sala, et al.
Transcatheter radiofrequency ablation of atrial fibrillation in patients with mitral valve prostheses and enlarged atria: Safety, feasibility, and efficacy
J. Am. Coll. Cardiol.,
March 15, 2005;
45(6):
868 - 872.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Khargi, B. A. Hutten, B. Lemke, and T. Deneke
Surgical treatment of atrial fibrillation; a systematic review
Eur. J. Cardiothorac. Surg.,
February 1, 2005;
27(2):
258 - 265.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P Jais, P Sanders, L F Hsu, M Hocini, and M Haissaguerre
Catheter ablation for atrial fibrillation
Heart,
January 1, 2005;
91(1):
7 - 9.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Mönnig, J. Wessling, K. U. Juergens, P. Milberg, M. Ribbing, R. Fischbach, J. Wiekowski, Gün. Breithardt, and L. Eckardt
Further evidence of a close anatomical relation between the oesophagus and pulmonary veins
Europace,
January 1, 2005;
7(6):
540 - 545.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. L. Page
Newly Diagnosed Atrial Fibrillation
N. Engl. J. Med.,
December 2, 2004;
351(23):
2408 - 2416.
[Full Text]
[PDF]
|
 |
|
|